{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:49:15Z","timestamp":1775058555416,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study shows the effect of a long-term treatment (60 cycles) with the ethinyl oestradiol\/cyproterone acetate pill, and the follow-up after 6 months from cessation, in polycystic ovarian syndrome. The 140 studied women had polycystic ovaries and moderate or severe acne, 108 also presented hirsutism. The endocrine profile significantly modified after six cycles (P &lt; 0.001), with a further significant decrease of gonadotrophins, oestrogens and androgens after 12 cycles, and a greater increase of sex hormone-binding globulins and insulin-like growth factor-binding globulins. Between the 12th and 60th cycle there was only a significant reduction of dehydroepiandrosterone sulphate (P &lt; 0.05). Acne disappeared in all patients within 12\u201324 cycles, but hirsutism was still present in 30.6% after 60 cycles. Mild-moderate hirsutism disappeared in 36\u201360 cycles, whereas severe hirsutism substantially decreased, but persisted. Ovarian volume, microcyst numbers and stroma percentage significantly decreased (P &lt; 0.01). After 6 months from the end of the therapy, endocrine parameters were identical to the starting ones, acne and hirsutism reappeared, whereas ovarian morphology was between the initial and final condition. Ovaries were polycystic in 42 (30%) patients and multifolliculars in 98 (70%). Our results show the effectiveness of this combination on androgenic symptoms, especially on acne, and suggest that acne and hirsutism are induced by different peripheral mechanisms.<\/jats:p>","DOI":"10.1093\/humrep\/16.1.36","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:50:44Z","timestamp":1027723844000},"page":"36-42","source":"Crossref","is-referenced-by-count":69,"title":["Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome"],"prefix":"10.1093","volume":"16","author":[{"given":"Leopoldo","family":"Falsetti","sequence":"first","affiliation":[{"name":"Department of Gynaecological Endocrinology, University of Brescia, Brescia 25128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Gambera","sequence":"additional","affiliation":[{"name":"Department of Gynaecological Endocrinology, University of Brescia, Brescia 25128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Tisi","sequence":"additional","affiliation":[{"name":"Department of Gynaecological Endocrinology, University of Brescia, Brescia 25128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,1,1]]},"reference":[{"key":"2019070202160419200_ACIEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Acien, P., Quereda, F., Matalli\u0300n, P. et al. (1999) Insulin, androgens and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil. Steril., 72, 32\u201340.","DOI":"10.1016\/S0015-0282(99)00184-3"},{"key":"2019070202160419200_ADAMS-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Adams, J., Polson, D.W., Abdulwahid, N. et al. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet, ii, 1375\u20131378.","DOI":"10.1016\/S0140-6736(85)92552-8"},{"key":"2019070202160419200_AONO-ETAL-1977","unstructured":"Aono, P., Miyazaki, M., Miyake, A. et al. (1977) Responses of serum gonadotropins to LH releasing hormones and estrogens in Japanese women with polycistic ovaries. Acta Endocrinol., 85, 840\u2013849."},{"key":"2019070202160419200_CARMINA-ETAL-1991","unstructured":"Carmina, E., Stanczyk, F.Z., Matteri, R. et al. (1991) Serum androsterone coniugates differentiate between acne and hirsutism in hyperandrogenic women. Fertil. Steril., 55, 872\u2013876."},{"key":"2019070202160419200_CASSIDENTI-ETAL-1991","unstructured":"Cassidenti, D.L., Paulson, R.J., Serafini, P. et al. (1991) Effects of sex steroids on skin 5\u03b1-reductase activity in vitro. Obstet. Gynecol., 78, 103\u2013110."},{"key":"2019070202160419200_CHAPMAN-ETAL-1982","unstructured":"Chapman, M.G., Jeffcoate, S.L. and Dewhurst, C.J. (1982) Effect of cyproterone acetate-ethinyl oestradiol tretment on adrenal function in hirsute women. Clin. Endocrinol., 17, 577\u2013582."},{"key":"2019070202160419200_CONWAY-ETAL-1989","unstructured":"Conway, G.S., Honour, J.W. and Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary sindrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol., 30, 459\u2013470."},{"key":"2019070202160419200_DAHLGREN-ETAL-1998","unstructured":"Dahlgren, E., Landin, K., Krotkiewski, M. et al. (1998) Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum. Reprod., 13, 2706\u20132711."},{"key":"2019070202160419200_DUFFY-ETAL-1995","unstructured":"Duffy, D.M., Legro, R.S., Chang, L. et al. (1995) Metabolism of dihydrotestosterone to 5\u03b1-androstane and 3\u03b1, 17\u03b2-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment. Fertil. Steril., 64, 736\u2013739."},{"key":"2019070202160419200_DULEBA-ETAL-1998","unstructured":"Duleba, A.J., Spaczynski, R.Z. and Olive, D.L. (1998) Insulin and insulin-like growth factor-1 stimulate the proliferation of human ovarian theca-intestinal cells. Fertil. Steril., 69, 335\u2013340."},{"key":"2019070202160419200_EBLING-ETAL-1971","doi-asserted-by":"crossref","unstructured":"Ebling, F.J., Ebling, E., McCaffey, V. et al. (1971) The response of the sebaceous glands of the hypophysectomized castrated male rat to 5\u03b1-dihydrotestosterone, androstenedione, dehydroepiandrosterone and androsterone. J. Endocrinol., 45, 245\u2013259.","DOI":"10.1677\/joe.0.0510181"},{"key":"2019070202160419200_EBLING-ETAL-1973","unstructured":"Ebling, F.J., Ebling, E., McCaffey, V. et al. (1973) The response of the sebaceous glands of the hypophysectomized castrated male rat to 5\u03b1-androstanedione and 5\u03b1-androstano-3\u03b2,17\u03b2-diol. J. Endocrinol., 60, 183\u2013187."},{"key":"2019070202160419200_FALSETTI-AND-PASINETTI-1995","unstructured":"Falsetti, L. and Pasinetti, E. (1995) Effects of long-term administartion of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Acta Obstet. Gynecol., 74, 56\u201360."},{"key":"2019070202160419200_FALSETTI-AND-ELEFTHERIOU-1996","doi-asserted-by":"crossref","unstructured":"Falsetti, L. and Eleftheriou, G. (1996) Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patientss. Gynecol. Endocrinol., 10, 319\u2013326.","DOI":"10.3109\/09513599609012818"},{"key":"2019070202160419200_FALSETTI-ETAL-1998","unstructured":"Falsetti, L., Rosina, B. and De Fusco, D. (1998) Serum levels of 3\u03b1-androstanediol glucuronide in hirsute and non hirsute women. Eur. J. Endocrinol., 138, 284\u2013289."},{"key":"2019070202160419200_FERRIMAN-AND-GALLWEY-1961","unstructured":"Ferriman, D. and Gallwey, J.D. (1961) Clinical assesment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440\u20131447."},{"key":"2019070202160419200_FRUZZETTI-ETAL-1999","unstructured":"Fruzzetti, F., Bersi, C., Parrini, D. et al. (1999) Treatment of hirsutism: comparison between different antiandrogens with central and peripheral effects. Fertil. Steril., 71, 445\u2013451."},{"key":"2019070202160419200_GIRARD-ETAL-1978","unstructured":"Girard, J., Baumann, K.B., Buchler, U. et al. (1978) Cyproterone acetate and ACTH adrenal function. J. Clin. Endocrinol. Metab., 47, 581\u2013586."},{"key":"2019070202160419200_GOLDZIEHER-AND-GREEN-1962","unstructured":"Goldzieher, J.W. and Green, J.A. (1962) The polycystic ovary: clinical and histological features. J. Clin. Endocrinol. Metab., 22, 325\u2013329."},{"key":"2019070202160419200_HARRIS-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Harris, G., Azoolina, B., Baginsky, W. et al. (1992) Identification and selective inhibition of an isozyme of steroid 5\u03b1-reductase in human scalp. Proc. Natl Acad. Sci. USA, 89, 10787\u201310791.","DOI":"10.1073\/pnas.89.22.10787"},{"key":"2019070202160419200_HERNANDEZ-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Hernandez, E.R., Resnick, C.E., Svoboda, M.E. et al. (1988) Somatomedin-C\/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology, 122, 1603\u20131609.","DOI":"10.1210\/endo-122-4-1603"},{"key":"2019070202160419200_IMPERATO-MCGINLEY-ETAL-1993","unstructured":"Imperato-McGinley, J., Gautier, T., Cai, L. et al. (1993) The androgen control of sebum production. Study of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J. Clin. Endocrinol. Metab., 76, 524\u2013528."},{"key":"2019070202160419200_KUTTEN-AND-MAUVAIS-JARVIS-1975","unstructured":"Kutten, F. and Mauvais-Jarvis, P. (1975) Testosterone 5\u03b1-reduction in the skin of normal subjects and of patients with abnormal sex development. Acta [Endocrinol., 79, 164\u2013176."},{"key":"2019070202160419200_LEGRO-ETAL-1998","unstructured":"Legro, R.S., Finegood, D. and Dunaif, A. (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 83, 2694\u20132698."},{"key":"2019070202160419200_LOBO-1991","unstructured":"Lobo, R.A. (1991) Hirsutism in polycystic ovary syndrome: current concepts. Clin. Obstet. Gynecol., 34, 817\u2013826."},{"key":"2019070202160419200_LOOKINGBILL-ETAL-1988","unstructured":"Lookingbill, D.P., Egan, N., Santen, R.J. et al. (1988) Correlation of serum 3\u03b1-adrostanediol glucuronide with acne and chest hair density in men. J. Clin. Endocrinol. Metab., 67, 986\u2013991."},{"key":"2019070202160419200_MARCONDES-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Marcondes, J.A., Wajchenberg, B.L., Abujamra, A.G. et al. (1990) Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects. Fertil. Steril., 53, 40\u201344.","DOI":"10.1016\/S0015-0282(16)53213-0"},{"key":"2019070202160419200_MATTERI-ETAL-1989","unstructured":"Matteri, R.K., Stanczyk, F.Z., Gentzchein, E. et al. (1989) Androgen sulfate and glucoronide coniugates in nonhirsute and hirsute women with polycystic ovary syndrome. Am. J. Obstet. Gynecol., 161, 1704\u20131709."},{"key":"2019070202160419200_MCKENNA-1993","unstructured":"McKenna, T.J. (1993) Variable androgen sensitivity in relationship in hirsutism and acne. Clin. Endocrinol., 39, 547\u2013549."},{"key":"2019070202160419200_MESTAYER-ETAL-1996","unstructured":"Mestayer, C.H., Berthaut, I., Portois, M.C. et al. (1996) Predominant expression of 5\u03b1-reductase type 1 in pubic skin from normal subjects and hirsute patients. J. Clin. Endocrinol. Metab., 81, 1989\u20131993."},{"key":"2019070202160419200_MOWSZOWITCZ-ETAL-1986","unstructured":"Mowszowitcz, I., Wright, F., Vicens, M. et al. (1986) Androgen metabolism in hirsute patients treated with cyproterone acetate. Steroid Biochem., 20, 757\u2013761."},{"key":"2019070202160419200_ORSINI-ETAL-1983","unstructured":"Orsini, L.F., Rizzo, N., Calderoni, P. et al. (1983) Ultrasound monitoring of the ovarian follicular development: a comparison of real time and static scanning techniques. J. Clin. Ultrasound, 11, 207\u2013213."},{"key":"2019070202160419200_PAULSON-ETAL-1986","unstructured":"Paulson, R.J., Serafini, P.C., Catalino, J.A. et al. (1986) Measurements of 3\u03b1,17\u03b2-androstanediol glucuronide in serum and urine and the correlation with skin 5\u03b1-reductase activity. Fertil. Steril., 46, 222\u2013226."},{"key":"2019070202160419200_PAUS-AND-COTSARELIS-1999","unstructured":"Paus, R. and Cotsarelis, G. (1999) The biology of hair follicles. N. Engl. J. Med., 341, 491\u2013497."},{"key":"2019070202160419200_PREVELIC-1997","unstructured":"Prevelic, G. (1997) Insulin resistance in polycystic ovary sindrome. Curr. Opin. Obstet. Gynecol., 9, 193\u2013201."},{"key":"2019070202160419200_PRELEVIC-ETAL-1990","unstructured":"Prelevic, G.M., Wurzburger, M.I., Trpkovic, D. et al. (1990) Effect of low-dose estrogen-antiandrogen combination (Diane 35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome. Gynecol. Endocrinol., 4, 157\u2013168."},{"key":"2019070202160419200_SPEROFF-AND-GLASS-1994","unstructured":"Speroff, L. and Glass, R. (1994) Clinical Gynecologic Endocrinology and Infertility, 5th edn. Williams & Wilkins, Baltimore, Chap. 14, pp. 483\u2013514."},{"key":"2019070202160419200_SUIKKARI-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Suikkari, A.M., Jalkanen, J., Koistinen, R. et al. (1989) Human granulosa cells synthesize low molecular weight insulin-like growth factor-binding protein. Endocrinology, 124, 1088\u20131094.","DOI":"10.1210\/endo-124-2-1088"},{"key":"2019070202160419200_SUIKKARI-ETAL-1991","unstructured":"Suikkari, A.M., Tiitinen, A., Stenman, U.H. et al. (1991) Oral contraceptives increase IGFBP-1 in women with polycystic ovary syndrome. Fertil. Steril., 55, 895\u2013899."},{"key":"2019070202160419200_TOSCANO-ETAL-1993","unstructured":"Toscano, V., Balducci, R., Bianchi, P. et al. (1993) Two different pathogenetic mechanisms may play a role in acne and hirsutism. Clin. Endocrinol., 39, 551\u2013556."},{"key":"2019070202160419200_VENTUROLI-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Venturoli, S., Marescalchi, O., Colombo, F.M. et al. (1999) A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J. Clin. Endocrinol. Metab., 84, 1304\u20131310.","DOI":"10.1210\/jcem.84.4.5591"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/16\/1\/36\/28894137\/160036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T04:36:30Z","timestamp":1682224590000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/16\/1\/36\/3113884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,1,1]]},"published-print":{"date-parts":[[2001,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/16.1.36","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,1]]},"published":{"date-parts":[[2001,1,1]]}}}